Nothing Special   »   [go: up one dir, main page]

Form 2.4 Informed Consent Evaluation Form 1 2024 versionNEW VERSION

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 3

University of Cebu

Academe
Research Ethics Committee
Informed Consent Evaluation Form
Form 2.4

Part 1. to be filled by the PI


PROTOCOL TITLE:
CANTEEN SERVICES
SATISFACTION SURVEY
PROTOCOL NO. : Type of Review:
PRINCIPAL INVESTIGATOR: CONTACT DETAILS: (email add & mobile number)
D/C PRACULLOS,DERRON P. anoymousderron@gmail.com/ 09165643149
ADVISER: CONTACT DETAILS: (email add & mobile number)
CARLY MAE SUICO, LPT MAED cmsuico@uc.edu.ph/09958439157
INSTITUTION: Status:
UNIVERSITY OF CEBU - METC ✘ NEW Re-submission

REVIEWER:

Part 2. to be filled by the ICF Reviewer


GUIDE FOR REVIEWING THE INFORM CONSENT PROCESS & FORM
1. Is it necessary to seek the Informed Consent of the participants?

Unable to Assess YES NO

IF NO, please explain

IF YES, are the participants provided with sufficient information about the following
items?

YES NO N/A
o Purpose of the study?

o Statement describing the purpose of the study


o Study-related treatments and probability for random
assignment
o Study procedures including all invasive procedures

o Responsibilities of the participant

o Approximate number of participants in the study


2

o Study aspects that are experimental


o Foreseeable risks to participant/embryo/ fetus/nursing
infant; including pain, discomfort, or inconvenience
associated with participation including risks to spouse
or partner;
o Risks (including possible discrimination)?
o Reasonably expected benefits; or absence of direct
benefit to participants, as applicable
o Expected benefits to the community or to society, or
contributions to scientific knowledge
o Expected duration of participation in the study
o Description of post-study access to the study product
or intervention that have been proven safe and
effective
o Alternative procedures or treatment available to
participant
o Compensation or insurance or treatment entitlements
of the participant in case of study-related injury
o Anticipated payment, if any, to the participant in the
course of the study; whether money or other forms of
material goods, and if so, the kind and amount
o Compensation (or no plans of compensation) for the
participant or the participant’s family or dependents in
case of disability or death resulting from study-
related injuries
o Discomforts and inconvenience?
o Who to contact for pertinent questions and/or for
assistance in research-related concerns or injury?
o Extent of
confidentiality?
2. Is the inform consent written or presented in non-technical language that participants can
understand?

Unable to Assess YES NO

3. Does the protocol include an adequate process for ensuring that the consent is voluntary?

Unable to Assess YES NO

4. Are the different types of consent forms (assent, patient representative) appropriate for the types
of study participants?

Unable to Assess YES NO

Review Ethics Committee | Form 2.4 | Informed Consent Evaluation Form 1-2024
3

5. Are the names and contact numbers from the research team and REC in the informed consent?

Unable to Assess YES NO

6. Is the Informed Consent translated into the local language/dialect? (if applicable)

Unable to Assess YES NO

7. Do you have any other concerns?

RECOMMENDATION:
APPROVED
Minor Revisions Required
Click or tap here to enter text.
Major Revisions Required
Click or tap here to enter text.
DISAPPROVED
Reasons for disapproval: Click or tap here to enter text.

Signature over Printed Name Date Reviewed

Review Ethics Committee | Form 2.4 | Informed Consent Evaluation Form 1-2024

You might also like